Skip to Content

267 NL75 (Indomethacin Extended-Release 75 mg)

Pill with imprint 267 NL75 is White, Capsule-shape and has been identified as Indomethacin Extended-Release 75 mg. It is supplied by Ingenus Pharmaceuticals, LLC.

Indomethacin is used in the treatment of back pain; bursitis; ankylosing spondylitis; bartter syndrome; cluster headaches and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 267 NL75

Indomethacin Extended-Release

Imprint
267 NL75
Strength
75 mg
Color
White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ingenus Pharmaceuticals, LLC
Manufacturer
Novast Laboratories, Ltd.
National Drug Code (NDC)
50742-0234
Inactive Ingredients
microcrystalline cellulose, lactose monohydrate, pregelatinized corn starch, povidone, sodium lauryl sulfate, magnesium silicate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, ammonio methacrylate copolymer type A, triethyl citrate, gelatin, titanium dioxide, shellac, ferrosoferric oxide, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.